Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy

Roberto Barriales-Villa1, Raúl Centurión-Inda, Xusto Fernández-Fernández

  • 1Instituto de Investigación Biomédica de A Coruña, A Coruña, España. rbarrialesv@gmail.com

Insights

Severe cardiac conduction disturbances requiring pacemakers are common in hypertrophic cardiomyopathy patients. A significant portion of these cases may have a genetic link, suggesting familial screening is important.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cardiac disease.
  • Cardiac conduction disturbances are a known complication of HCM.
  • The prevalence and characteristics of severe conduction issues requiring pacemakers in HCM are not fully understood.

Purpose of the Study:

  • To determine the prevalence of severe cardiac conduction disturbances in a large cohort of HCM patients.
  • To characterize patients with HCM who require permanent pacemaker implantation.
  • To describe the outcomes for HCM patients receiving pacemakers and explore potential familial links.

Main Methods:

  • Retrospective analysis of 451 patients diagnosed with hypertrophic cardiomyopathy.
  • Review of medical records to identify patients who received permanent pacemaker implantation.
  • Analysis of reasons for pacemaker implantation, including sinus node dysfunction and atrioventricular conduction disturbances.
  • Assessment of family history for pacemaker implantation.

Main Results:

  • Permanent pacemaker implantation was required in 48 patients (11%) of the cohort.
  • Sinus node dysfunction accounted for 20 pacemaker implantations, while 28 were for atrioventricular conduction disturbances.
  • Primary bradyarrhythmia led to pacemaker implantation in 36 patients (8%).
  • A familial component was noted, with 18% of patients having at least one family member with a permanent pacemaker.

Conclusions:

  • Severe cardiac conduction disturbances requiring permanent pacemaker implantation are prevalent in hypertrophic cardiomyopathy.
  • Hypertrophic cardiomyopathy patients necessitating pacemakers exhibit specific conduction issues like sinus node dysfunction and AV block.
  • The observed familial occurrence suggests a potential genetic basis for severe conduction disturbances in HCM, warranting further investigation and family screening.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...